GLENMARK PHARMACEUTICALS (NSE:GLENMARK) Price Target Increased by 15.58% to 594.15
The average one-year price target for GLENMARK PHARMACEUTICALS (NSE:GLENMARK) has been revised to 594.15 / share. This is an increase of 15.58% from the prior estimate of 514.08 dated May 10, 2023.
The price target is an average of many targets provided by analysts. The latest targets range from a low of 434.30 to a high of 737.10 / share. The average price target represents a decrease of 2.42% from the latest reported closing price of 608.90 / share.
See our leaderboard of companies with the largest price target upside.
- For more in-depth coverage of GLENMARK PHARMACEUTICALS, view the free, crowd-sourced company research report on Finpedia.
What are Other Shareholders Doing?